Lincoln Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '24
Dec '23
Sep '23
Jun '23
Mar '23
Total Qtr Revenue cr
149.51
157.47
164.68
143.31
116.36
Other Income Qtr Cr7.0211.028.697.693.90
Operating Revenues Qtr142.49146.45155.99135.62112.46

*All values are in Cr.

Operating Expenses Qtr
124.11
116.79
124.84
114.90
95.82
Operating Profit Qtr
18.38
29.66
31.15
20.72
16.64
EBIDT Qtr Cr
25.40
40.68
39.84
28.41
20.54
Depreciation Qtr
2.69
2.81
2.58
2.55
2.41
Net Profit Qtr
18.60
28.04
27.65
19.01
12.56
Basic EPS Qtr
9.28
14.00
13.81
9.49
6.27
Open Demat Account
or Resume your Application
+91 -

personImage